Jefferies Cuts PT on Dynavax (DVAX), Sees Heplisav Delayed Until 2016
Tweet Send to a Friend
Jefferies slashed its price target on Dynavax Technologies (NASDAQ: DVAX) from $5 to $3 but maintained a Buy rating after ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


